From Department of Medical Education, California University of Science and Medicine (EG, SE).
J Am Board Fam Med. 2022 Jul-Aug;35(4):680-685. doi: 10.3122/jabfm.2022.04.210437.
The ongoing COVID-19 pandemic initiated the implementation of numerous disease mitigation strategies aimed to prevent transmission of the SARS-CoV-2. Given the similarity in mode of transmission, we posit that these strategies have also had a collateral benefit in minimizing the transmission of influenza during the 2020 to 2021 season in California.
Five years of data including incidence of influenza-like illness (ILI), influenza hospitalization, and mortality related to influenza in California were analyzed.
In each of these parameters, there was a marked decrease in influenza activity, suggesting the additional benefit of COVID-19 mitigation strategies on influenza prevention.
Further study is recommended to determine which specific variables had greater impact on transmission of respiratory viruses, and therefore can be utilized to prevent future outbreaks of respiratory illness.
持续的 COVID-19 大流行促使实施了许多疾病缓解策略，旨在防止 SARS-CoV-2 的传播。鉴于传播方式相似，我们假设这些策略在加利福尼亚州 2020 年至 2021 年流感季节也有减少流感传播的附带好处。
分析了加利福尼亚州五年的流感样疾病（ILI）发病率、流感住院和与流感相关的死亡率的数据。
在这些参数中，流感活动明显减少，这表明 COVID-19 缓解策略对预防流感有额外的益处。
建议进一步研究以确定哪些特定变量对呼吸道病毒传播的影响更大，从而可以利用这些变量来预防未来的呼吸道疾病爆发。
